Protect Your Trading Account With Options!

From Tradewins | Ad

This might be the opposite of what you’ve heard, but the real risk in the market now lies with stock trading… “Options Trading Made Easy” by expert Chuck Hughes will show you how the nature of options trading gives you the chance to profit no matter which way the market trends!

Get the e-book today!

>>>

Riccardo Perfetti, insider at Applied Therapeutics

Riccardo Perfetti Insider Information

Insider of Applied Therapeutics

Riccardo Perfetti, M.D., Ph.D. has served as Chief Medical Officer of Applied Therapeutics since August 2018. Before joining us, Dr. Perfetti served as a Senior Medical Officer, Vice President and Head of Global Medical Affairs, Diabetes and Cardiovascular Business Unit at Sanofi S.A., a publicly traded pharmaceutical company, from October 2007 to August 2018. Prior to joining Sanofi, Dr. Perfetti served in various roles at Amgen Inc., a publicly traded biopharmaceutical company, including as a Director and Global Development Leader in diabetes, obesity, metabolism and endocrinology from December 2004 to August 2007. Dr. Perfetti was previously an associate professor of medicine at University of California in Los Angeles and a professor of medicine at the National Institutes of Health (NIH). Dr. Perfetti practiced as an endocrinologist at Cedars-Sinai Medical Center and also served as Director of the Diabetes Research Laboratory and Director of the Outpatient Diabetes Program. Dr. Perfetti received his M.D. and Ph.D. in Endocrinology from University La Sapienza in Rome, Italy and received post-graduate training in endocrinology and molecular biology at NIH.

What is Riccardo Perfetti's net worth?: The estimated net worth of Riccardo Perfetti is at least $12,975.00 as of August 9th, 2021. Dr. Perfetti owns 15,000 shares of Applied Therapeutics stock worth more than $12,975 as of July 3rd. This net worth evaluation does not reflect any other investments that Dr. Perfetti may own. Additionally, Dr. Perfetti receives a salary of $792,250.00 as Insider at Applied Therapeutics. Learn More about Riccardo Perfetti's net worth.
How old is Riccardo Perfetti?: Dr. Perfetti is currently 62 years old. There are 4 older executives and no younger executives at Applied Therapeutics. Learn More on Riccardo Perfetti's age.
What is Riccardo Perfetti's salary?: As the Insider of Applied Therapeutics, Inc., Dr. Perfetti earned a total compensation package of $1,991,526.00 in 2020. Dr. Perfetti earned a salary of $472,500.00, a bonus of $189,000.00, options awards of $1,319,382.00, and other compensation of $10,644.00. Learn More on Riccardo Perfetti's salary.
How do I contact Riccardo Perfetti?: The corporate mailing address for Dr. Perfetti and other Applied Therapeutics executives is 340 MADISON AVENUE 19TH FLOOR, NEW YORK NY, 10173. Applied Therapeutics can also be reached via phone at (212) 220-9226 and via email at [email protected] Learn More on Riccardo Perfetti's contact information.
Has Riccardo Perfetti been buying or selling shares of Applied Therapeutics?: Riccardo Perfetti has not been actively trading shares of Applied Therapeutics over the course of the past ninety days. As an example of a recent trade by , on Sunday, July 3rd, 0 shares of BMO Capital Markets stock. Learn More on Riccardo Perfetti's trading history.
Who are Applied Therapeutics' active insiders?: Applied Therapeutics' insider roster includes Riccardo Perfetti (Insider), Shoshana Shendelman (CEO), and Charles Silberstein (CFO). Learn More on Applied Therapeutics' active insiders.
Are insiders buying or selling shares of Applied Therapeutics?: During the last twelve months, Applied Therapeutics insiders bought shares 4 times. They purchased a total of 3,543,249 shares worth more than $3,592,611.49. During the last twelve months, insiders at the sold shares 5 times. They sold a total of 31,825 shares worth more than $543,606.65. The most recent insider tranaction occured on June, 27th when Major Shareholder Real Estate Equitie Alexandria bought 3,500,000 shares worth more than $3,500,000.00. Insiders at Applied Therapeutics own 32.6 % of the company. Learn More about insider trades at Applied Therapeutics.
Information on this page was last updated on 6/27/2022.

Riccardo Perfetti Insider Trading History at Applied Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/23/2022	Buy	30,000	$1.97	$59,100.00
3/21/2022	Buy	12,548	$1.85	$23,213.80
8/9/2021	Sell	15,000	$17.39	$260,850.00	15,000
7/28/2021	Sell	15,000	$17.50	$262,500.00	15,000
7/15/2021	Sell	460	$19.54	$8,988.40
7/13/2021	Sell	460	$21.25	$9,775.00
6/7/2021	Sell	460	$20.97	$9,646.20	460
6/4/2021	Sell	460	$19.65	$9,039.00	460
5/25/2021	Sell	460	$17.97	$8,266.20	1,640
5/11/2021	Sell	200	$17.27	$3,454.00	200
4/30/2021	Sell	2,560	$18.39	$47,078.40	1,640
4/28/2021	Sell	1,640	$18.44	$30,241.60	1,640
4/14/2021	Sell	200	$17.11	$3,422.00	200
3/30/2021	Sell	460	$18.43	$8,477.80	465
3/26/2021	Sell	465	$19.68	$9,151.20	465
3/15/2021	Sell	465	$19.61	$9,118.65	465
3/12/2021	Sell	465	$19.38	$9,011.70	465
2/25/2021	Sell	1,295	$23.20	$30,044.00	465
2/23/2021	Sell	465	$21.84	$10,155.60	465
2/3/2021	Sell	1,295	$26.79	$34,693.05	3,785
2/1/2021	Sell	1,460	$25.30	$36,938.00	3,785
1/21/2021	Sell	465	$20.30	$9,439.50	465
1/19/2021	Sell	465	$21.83	$10,150.95	465
1/8/2021	Sell	16,515	$23.23	$383,643.45	7,765
1/6/2021	Sell	7,765	$23.47	$182,244.55	7,765
12/29/2020	Sell	465	$21.95	$10,206.75	465
12/9/2020	Sell	465	$20.46	$9,513.90	465
12/7/2020	Sell	465	$20.49	$9,527.85	465
11/23/2020	Sell	465	$20.59	$9,574.35	1,660
11/20/2020	Sell	1,660	$19.07	$31,656.20	1,660
11/10/2020	Sell	200	$17.59	$3,518.00	200
10/29/2020	Sell	465	$17.27	$8,030.55	465
10/27/2020	Sell	465	$21.20	$9,858.00	465

Riccardo Perfetti Buying and Selling Activity at Applied Therapeutics

Applied Therapeutics Company Overview

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Today's Range

Now: $0.87

$0.86

$0.94

50 Day Range

MA: $1.44

$0.76

$2.05

2 Week Range

Now: $0.87

$0.73

$22.27

Volume

401,173 shs

Average Volume

890,136 shs

Market Capitalization

$22.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.71

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

Riccardo Perfetti Insider Information

What is Riccardo Perfetti's net worth?

How old is Riccardo Perfetti?

What is Riccardo Perfetti's salary?

How do I contact Riccardo Perfetti?

Has Riccardo Perfetti been buying or selling shares of Applied Therapeutics?

Who are Applied Therapeutics' active insiders?

Are insiders buying or selling shares of Applied Therapeutics?